Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
Céline Callens(Université Paris Sciences et Lettres), Arnaud Pigneux(Centre Hospitalier Universitaire de Bordeaux), Françoise Rigal‐Huguet(Hôpital Purpan), Sandrine Meyer‐Monard(University Hospital of Basel), Pierre Fenaux(Saint Louis University Hospital), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Stéphane de Botton(Université Paris-Saclay), Christine Chomienne(Inserm), Anne Vekhoff(Hôtel-Dieu de Paris), Thierry Lamy(Centre Hospitalier Universitaire de Lille), Sylvie Chevret(Saint Louis University Hospital), Emmanuel Raffoux(Inserm), A. M. Stoppa(Centre Hospitalier Universitaire de Lille), Nathalie Fegueux(European Union), Xavier Thomas(Hôpital Lyon Sud), Audrey Ferrand(Inserm), Bruno Cassinat(Inserm), JM Cayuela(Hôpital Saint-Louis), Hervé Dombret(University of London Institute in Paris), A. Guerci(University of Bern)
Cited by 139
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k